Acasti Pharma Inc (NASDAQ:ACST) fell 4.5% last week after announcing its fiscal Q1 2022 financial results for the period ended June 30, 2021, and provided a business update. The company posted a loss of $3.1 million or $0.01 on a per-share basis, a decrease from a net loss of $4.7 million or $0.05 per share a year ago. The net loss reduction resulted from reduced R&D expenses following the completion…
Venus Concept Inc (NASDAQ:VERO) Stock Continues to Move Lower: What Next?
Venus Concept Inc (NASDAQ:VERO) dropped 2% after announcing its Q2 2021 financial results for six months ending June 30, 2021. In Q2 2021, the company reported a 52% YoY revenue growth to $25.8 million with a gross margin of 72.5%. Adjusted EBITDA was 117% up YoY to $0.5 million. During the quarter, Health Canada issued the company a medical device license to sell the country’s Venus Fiore Feminine Health System….
Healthier Choices Management Corp (OTCMKTS:HCMC) Stock Fell 25% Last Week: A Good Opportunity?
It was a pretty hard time for investors in the Healthier Choices Management Corp (OTCMKTS:HCMC) stock last week as it suffered from a major selloff. Over the course of the previous week, the Healthier Choices Management stock tanked by as much as 25% and it now remains to be seen if the stock can actually make a recovery this week. In this context, it may be important for investors to…
Net Savings Link (OTCMKTS:NSAV) Stock Continues to See Profit Booking: A Good Buy Now?
Not too long ago, the cryptocurrency, blockchain and digital asset technology company Net Savings Link (OTCMKTS:NSAV) had seen its stock make enormous gains. However, the situation changed quite dramatically last week after the company launched its own cryptocurrency exchange. It is important to note in this regard that the launch of the new exchange had been one of the major reasons behind the rally in the stock in the first…
VGTel Inc (OTCMKTS:VGTL) Stock Jumps On High Volume: But Why?
It is not uncommon for stocks to record enormous gains despite there being no news and that is the sort of move that happened in the VGTel Inc (OTCMKTS:VGTL) stock this past Friday. Despite there being no news about the company at all, the multi-platform entertainment company saw its stock soar by as much as 58% on Friday as investors piled on to the stock in a big way. In…
CNS Pharmaceuticals Inc (NASDAQ:CNSP) Stock Trends Lower: Will it Rebound?
As more and more companies report their quarterly financial results, it is perhaps time for investors to take a look at many of those and one of the companies one could take a look into is CNS Pharmaceuticals Inc (NASDAQ:CNSP). This past Friday the company announced its financial results for the quarter that concluded on June 30, 2021 and upon the announcement, the CNS stock ended up with gains of…
Citius Pharmaceuticals Inc (NASDAQ:CTXR) Stock Continues to Trend Lower: Now What?
The biopharmaceutical firm Citius Pharmaceuticals Inc (NASDAQ:CTXR) was in focus among many investors on Friday after the company announced its financial results for the third fiscal quarter of the year for the period ended on June 30, 2021. The stock ended the day with gains of 2% and it is likely to be in focus among many investors today as well. In this situation, it might be a good idea…
CytoDyn Inc (OTCMKTS:CYDY) Stock Attempts To Bounce Back: Will it Sustain?
The presence of activist investors in a company can often lead to a fair degree of uncertainty for investors but last week the CytoDyn Inc (OTCMKTS:CYDY) stock actually performed strongly. There was no news about the biopharmaceutical company last week but the stock performed strongly. On Friday, it jumped by 5% and ended the week with gains of as much as 12.50%. In this situation, it might be a good…
CASI Pharmaceuticals Inc (NASDAQ:CASI) Stock Moves Up Suddenly: A Bullish Sign?
The biopharmaceutical company CASI Pharmaceuticals Inc (NASDAQ: CASI) stock was on the radars of many investors this past Friday and ended the day with gains of as much as 13% amidst heavy action. The company, which is involved in the development of the development and commercialisation of novel pharmaceutical products and therapies, announced its financial results for the second fiscal quarter of 2021 on Thursday. In the second quarter that…
Corbus Pharmaceuticals Inc (NASDAQ:CRBP) Stock Fell 7% Last Week: How to Trade This Week?
While many stock performed strongly last week, there were many other stocks which were laggards and that is the nature of the market. The Corbus Pharmaceuticals Inc (NASDAQ:CRBP) stock was in the latter category as it slumped by as much as 7% last week. Considering the fall in the stock, it could also be a good idea to figure out if it could be an opportunity for investors. Last week…